Lateralized and unilateral manifestations of systemic lupus erythematosus: a systematic review with descriptive pooled mapping

Background Systemic lupus erythematosus (SLE) is a multisystem autoimmune disease with heterogeneous clinical expression. SLE-related processes may occasionally present as unilateral, asymmetric, hemispheric, or anatomically focal syndromes that mimic stroke, cranial neuropathy, orbital disease, pleural pathology, infection, malignancy, or other localized disorders. This review aimed to classify lateralized manifestations of SLE and examine their organ-system distribution, laterality, proposed mechanisms, diagnostic implications, treatments, and outcomes. Methods PubMed/MEDLINE, Google Scholar, Scopus, Web of Science Core Collection, WOS-EMR, Crossref, and reference lists were searched through 12 June 2026. A targeted supplementary search for asymmetric and focal articular manifestations was completed on 14 July 2026. Two reviewers independently screened records and extracted data, resolving disagreements through discussion and consensus. Methodological limitations were evaluated descriptively using design-appropriate appraisal domains. Findings were synthesized using structured narrative synthesis and descriptive study-level evidence mapping. Formal meta-analysis was not performed because of substantial clinical and methodological heterogeneity. Results Forty studies were included. Neurovascular manifestations were reported in 13 studies (32.5%), cranial nerve and brainstem syndromes in seven (17.5%), ocular and orbital manifestations in six (15.0%), pleural and thoracic manifestations in four (10.0%), movement disorders in three (7.5%), articular and musculoskeletal manifestations in three (7.5%), neurocognitive or neurophysiological lateralization in two (5.0%), and cutaneous, facial, or focal soft-tissue manifestations in two (5.0%). After re-extraction from full reports when available and complete available records otherwise, right-sided involvement was classified in 14 studies, left-sided involvement in nine, and mixed, bilateral, multifocal, or case-series-level patterns in seven. Five studies described unilateral or focal involvement without an extractable exact side, and five analytical studies lacked consistently extractable patient-level laterality. The study-level imbalance did not establish a population-level right- or left-sided predominance. Conclusions Lateralized manifestations of SLE form a clinically diverse, multisystem spectrum. Their clinical importance lies in distinguishing thrombotic, inflammatory, vasculitic, neuropathic, and organ-specific mechanisms while excluding more common localized causes. The predominantly case-based evidence does not support population-level frequency estimates, comparative treatment effects, or side predominance. Standardized reporting and multicenter studies are needed to clarify mechanisms, recurrence, treatment response, and outcomes.

Authors

Publication Details

Journal
BMC Rheumatology
Published
2026-11-19
DOI
https://doi.org/10.1186/s41927-026-00714-z
Primary Topic
Systemic Lupus Erythematosus Research
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
article

Lateralized and unilateral manifestations of systemic lupus erythematosus: a systematic review with descriptive pooled mapping

Mona Muhe Eldeen Eshag, Ziryab Imad Taha Mahmoud, Asim Ahmed
BMC Rheumatology
Systemic Lupus Erythematosus Research
article

Lateralized and unilateral manifestations of systemic lupus erythematosus: a systematic review with descriptive pooled mapping

Mona Muhe Eldeen Eshag, Ziryab Imad Taha Mahmoud, Asim Ahmed
article en

Abstract

Background Systemic lupus erythematosus (SLE) is a multisystem autoimmune disease with heterogeneous clinical expression. SLE-related processes may occasionally present as unilateral, asymmetric, hemispheric, or anatomically focal syndromes that mimic stroke, cranial neuropathy, orbital disease, pleural pathology, infection, malignancy, or other localized disorders. This review aimed to classify lateralized manifestations of SLE and examine their organ-system distribution, laterality, proposed mechanisms, diagnostic implications, treatments, and outcomes. Methods PubMed/MEDLINE, Google Scholar, Scopus, Web of Science Core Collection, WOS-EMR, Crossref, and reference lists were searched through 12 June 2026. A targeted supplementary search for asymmetric and focal articular manifestations was completed on 14 July 2026. Two reviewers independently screened records and extracted data, resolving disagreements through discussion and consensus. Methodological limitations were evaluated descriptively using design-appropriate appraisal domains. Findings were synthesized using structured narrative synthesis and descriptive study-level evidence mapping. Formal meta-analysis was not performed because of substantial clinical and methodological heterogeneity. Results Forty studies were included. Neurovascular manifestations were reported in 13 studies (32.5%), cranial nerve and brainstem syndromes in seven (17.5%), ocular and orbital manifestations in six (15.0%), pleural and thoracic manifestations in four (10.0%), movement disorders in three (7.5%), articular and musculoskeletal manifestations in three (7.5%), neurocognitive or neurophysiological lateralization in two (5.0%), and cutaneous, facial, or focal soft-tissue manifestations in two (5.0%). After re-extraction from full reports when available and complete available records otherwise, right-sided involvement was classified in 14 studies, left-sided involvement in nine, and mixed, bilateral, multifocal, or case-series-level patterns in seven. Five studies described unilateral or focal involvement without an extractable exact side, and five analytical studies lacked consistently extractable patient-level laterality. The study-level imbalance did not establish a population-level right- or left-sided predominance. Conclusions Lateralized manifestations of SLE form a clinically diverse, multisystem spectrum. Their clinical importance lies in distinguishing thrombotic, inflammatory, vasculitic, neuropathic, and organ-specific mechanisms while excluding more common localized causes. The predominantly case-based evidence does not support population-level frequency estimates, comparative treatment effects, or side predominance. Standardized reporting and multicenter studies are needed to clarify mechanisms, recurrence, treatment response, and outcomes.

BMC Rheumatology
Systemic Lupus Erythematosus Research
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon